AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2024
Aug 7, 2024
29755_dirs_2024-08-07_90ad4515-3a29-48bb-a38a-3fbf172493c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2024-08-05
Reporting Person: GONZALEZ RICHARD A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-05 | Common Stock, $0.01 par value | S | 66500 | $186.52 | Disposed | 446599 | Direct |
Footnotes
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.50 to $186.90 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
More from AbbVie Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4